Pharmaceutical Technology
April 02, 2010
Inside USP
34
4
Collaboration has been key to the pharmacopeia's achievement.
April 02, 2010
Special Report
34
4
Tablets and capsules are mainstay product forms, so what are the spending and innovation trends for solid-dosage manufacturing equipment and machinery?
April 02, 2010
Inside EDQM
34
4
As drug manufacturing and standards grow, pharmacopeias must adapt to meet new challenges.
April 02, 2010
Peer-Reviewed Research
34
4
In Part I of this article, which appeard in the March 2010 issue, the authors describe their approach for constructing form spaces for carbamazepine, cimetidine, and phenylbutazone by initial solvent screening to evaluate the feasibility of spherical crystallization. Part II of this article discusses their findings.
April 02, 2010
Guest Editorial
34
4
As the industry continues to evolve, do we know where we're headed?
April 02, 2010
PharmTech Talk
34
4
An established show has several new programs that reflect the industry's current challenges.
April 02, 2010
Agent-in Place
34
4
Laboratory personnel share interesting tales as well as stories of unexpected tails.
April 02, 2010
Peer-Reviewed Research
34
4
The authors examined the disintegration and dissolution profiles of propranolol and rofecoxib tablets overencapsulated with standard hard-gelatin capsules and with capsules specifically designed for double-blind clinical trials.
April 02, 2010
In the Spotlight
34
4
Editors' Picks of Pharmaceutical Science and Technology Innovations
April 02, 2010
News
34
4
As demand for global vaccine development and production grows, all eyes are turning to Asia.
April 02, 2010
Peer-Reviewed Research
34
4
The authors describe a novel approach for assessing method robustness. This article contains online-bonus material and was copublished with Pharmaceutical Technology Europe.
April 02, 2010
Viewpoint
34
4
The BIO convention, and healthcare reform, could re-energize biotech.
April 02, 2010
Special Report
34
4
Pharmaceutical Technology's annual survey on equipment and machinery reveals the spending levels and types of spending made in 2009 and planned for 2010.
April 02, 2010
Special Report
34
4
The authors describe the origins of single-use components and explain their application to aseptic processes. They also show how disposable devices have changed over time and offer a glimpse of the future.
April 02, 2010
Outsourcing Outlook
34
4
Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization.
April 02, 2010
Washington Report
34
4
FDA lacks resources to manage expanding postmarketing responsibilities.
April 02, 2010
Industry Leaders: Q&A
34
4
Steve Sirabian discusses challenges, trends, and more.
April 02, 2010
Ingredients Insider
34
4
Growth in the market for monoclonal antibodies, recombinant proteins, and vaccines creates new opportunities for drug companies and suppliers.
April 02, 2010
Packaging Forum
34
4
Aseptic blow–fill–seal minimizes human intervention in the packaging process.
April 02, 2010
Online Exclusives
34
4
New information improves an organization's guide to building manufacturing facilities.
April 01, 2010
Issue PDF
34
4
Spending More Or Less, And On What?